Mitosol Side Effects

Generic name: mitomycin ophthalmic

Medically reviewed by Drugs.com. Last updated on Jul 17, 2024.

Note: This document provides detailed information about Mitosol Side Effects associated with mitomycin ophthalmic. Some dosage forms listed on this page may not apply specifically to the brand name Mitosol.

Applies to mitomycin ophthalmic: ophthalmic powder for solution.

Other dosage forms:

• topical application pad, topical application powder for solution

Precautions

Your eye doctor will check your eyes closely to make sure it is working properly and is not causing unwanted effects.

Receiving this medicine while you are pregnant can harm your unborn baby. If you are a woman who can get pregnant, your doctor may do tests to make sure you are not pregnant before receiving this medicine. Use an effective form of birth control to keep from getting pregnant. If you think you have become pregnant while receiving the medicine, tell your doctor right away.

This medicine may increase the risk of cataracts. Tell your doctor right away if you have blindness, blurred vision, or decreased vision.

Tell your doctor right away if you have decreased vision or any changes in your vision. These could be symptoms of hypotony (decreased tension or pressure in the eye).

Serious side effects of Mitosol

Along with its needed effects, mitomycin ophthalmic (the active ingredient contained in Mitosol) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking mitomycin ophthalmic:

Other side effects of Mitosol

Some side effects of mitomycin ophthalmic may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

For healthcare professionals

Applies to mitomycin ophthalmic: intraocular solution, ophthalmic kit.

General adverse events

The most commonly reported side effects include blebitis, corneal changes, and other localized reactions.^[Ref]

Ocular

• Frequency not reported: Blebitis, bleb ulceration, chronic bleb leak, encapsulated/cystic bleb, bleb-related infection, conjunctival necrosis, thin-walled bleb, Descemet's detachment, induced astigmatism, corneal epithelial damage, superficial punctate keratitis, endophthalmitis, hypotony, choroidal reaction, choroidal detachment, choroidal reactions, choroidal detachment, choroidal effusion, serious choroidal detachment, suprachoroidal hemorrhage, hypotony maculopathy, presence of supraciliochoroidal effusion, iritis, cataract development, capsular constriction, posterior synechiae, retinal pigment epithelial tear, serous/rhegatogenous retinal detachment, hyphema, vitreal/retinal/subconjunctival/disk hemorrhage, macular edema, sclera thinning/ulceration, intraocular lens capture, disk swelling, malignant glaucoma, lacrimal drainage system obstruction, ciliary block, corneal vascularization, decreased visual acuity, cystic conjunctival degeneration, upper eyelid retraction, dislocated implants, severe loss of vision, hemiretinal/central retinal vein occlusion^[Ref]

Other

• Frequency not reported: Wound dehiscence/scleral wound dehiscence^[Ref]

Cardiovascular

• Frequency not reported: Blood clot^[Ref]

See also:

Further information

Mitosol side effects can vary depending on the individual. Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Note: Medication side effects may be underreported. If you are experiencing side effects that are not listed, submit a report to the FDA by following this guide.

Medical Disclaimer